These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38272259

  • 1. Neuropsychological performance and disease burden in individuals at risk of developing Huntington disease.
    Paz-Rodríguez F, Chávez-Oliveros M, Bernal-Pérez A, Ochoa-Morales A, Martínez-Ruano L, Camacho-Molina A, Rodríguez-Agudelo Y.
    Neurologia (Engl Ed); 2024 Mar; 39(2):127-134. PubMed ID: 38272259
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychological performance and disease burden in individuals at risk of developing Huntington disease.
    Paz-Rodríguez F, Chávez-Oliveros M, Bernal-Pérez A, Ochoa-Morales A, Martínez-Ruano L, Camacho-Molina A, Rodríguez-Agudelo Y.
    Neurologia (Engl Ed); 2021 Jun 02. PubMed ID: 34090718
    [Abstract] [Full Text] [Related]

  • 3. Psychological discomfort in carriers and non-carriers of the Huntington disease mutation and its relationship with disease burden.
    Rodríguez-Agudelo Y, Chávez-Oliveros M, Ochoa-Morales A, Martínez-Ruano L, Camacho-Molina A, Paz-Rodríguez F.
    Neurologia (Engl Ed); 2022 Sep 01. PubMed ID: 36058517
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study.
    Cheng YF, Liu KC, Yang TM, Xiao Y, Jiang QR, Huang JX, Zhang S, Wei QQ, Ou RW, Li CY, Gu XJ, Burgunder JM, Shang HF.
    Brain Behav; 2023 Nov 01; 13(11):e3258. PubMed ID: 37849450
    [Abstract] [Full Text] [Related]

  • 5. Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.
    Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group.
    J Int Neuropsychol Soc; 2015 Jan 01; 21(1):8-21. PubMed ID: 26304055
    [Abstract] [Full Text] [Related]

  • 6. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I, Vinther-Jensen T, Gade A, Nielsen JE, Vogel A.
    J Int Neuropsychol Soc; 2015 Mar 01; 21(3):193-202. PubMed ID: 25850430
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP, Larsen IU, Jørgensen K, Vinther-Jensen T, Vogel A.
    J Huntingtons Dis; 2020 Mar 01; 9(1):59-68. PubMed ID: 31658065
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.
    Smith MM, Mills JA, Epping EA, Westervelt HJ, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group.
    Neuropsychology; 2012 Sep 01; 26(5):664-9. PubMed ID: 22846033
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
    Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R.
    J Neurol; 2004 Aug 01; 251(8):935-42. PubMed ID: 15316797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
    Kloos AD, Kegelmeyer DA, Fritz NE, Daley AM, Young GS, Kostyk SK.
    J Huntingtons Dis; 2017 Aug 01; 6(4):363-370. PubMed ID: 29254103
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
    Sešok S, Bolle N, Kobal J, Bucik V, Vodušek DB.
    Psychiatr Danub; 2014 Sep 01; 26(3):239-48. PubMed ID: 25191771
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.